drugset / Trial / NCT01161563

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

NCT01161563

Phase 4 Completed 118 enrolled Watson Pharmaceuticals
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to compare how subjects feel after receiving injections of two different types of GnRH six months apart. One injection is given under the skin of the abdomen, and the other one into the muscle of the buttock or thigh.

Timeline

Start
2010-07
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Leuprolide Other / unclassified 45 mg Subcutaneous
Comparator Triptorelin Other / unclassified 22.5 mg Intramuscular

Indications